Objective: Reactive oxygen species (ROS) and free radicals are involved in pathogenesis of cancer. D-Limonene, a monoterpene present in citrus fruit has been reported for its potential anticancer activities. The aim of present study was to evaluate the antioxidant effect of D-Limonene. Test solutions with different in vitro Material and methods: concentration of D-Limonene and Trolox (standard) were prepared. Six different antioxidant assays such as In vitro DPPH, ABTS, FRAP, iron chelating, hydroxyl radical scavenging and superoxide radical scavenging assay were performed for evaluation of antioxidant activity of D-Limonene. D-Limonene has shown appreciable Results: antioxidant activity in comparison with Trolox. The IC of D-Limonene in DPPH ( ABTS ( ,), 50 384.73 M), 603.23 M FRAP ( ), iron chelating ( , hydroxyl radical scavenging ( ) and superoxide radical -589.85 M -18475.5 M) 442.75 M scavenging assay ( was comparable with Trolox the IC value of Trolox DPPH ( ABTS 50 692.89 M) 153.30 M), ( ,), FRAP ( ), iron chelating ( , hydroxyl radical scavenging ( ) and 203.37 M -171.73 M 225.96 M) 146.37 M superoxide radical scavenging assay ( In vitro antioxidant assays has shown Conclusion: 105.25 M) respectively. concentration dependent reduction in free radical formation by D-Limonene in comparison with Trolox in all assays except iron chelating assay which suggests its promising role for cancer treatment.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: